Literature DB >> 2994900

Lyophilized combination pools of enterovirus equine antisera: new LBM pools prepared from reserves of antisera stored frozen for two decades.

J L Melnick, I L Wimberly.   

Abstract

This paper describes the preparation and test procedures for a second batch of lyophilized LBM combination antiserum pools, A through H, used for identifying 42 enteroviruses. Each pool is selectively composed of 10 or 11 of 42 individual enterovirus equine sera so that it contains 500 antibody units of each serum component per 0.1 ml. The new pools have been constituted from equine monovalent antisera that were prepared during the period 1962-67 and then evaluated and standardized in a series of collaborative international studies. An essential aspect of preparing the new pools was ensuring that the individual sera had retained high antibody titres through the long period of storage. At the time of retesting, the original stocks of these monovalent sera had been stored frozen at -20 degrees C for periods ranging from 16 to 20 years.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994900      PMCID: PMC2536437     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  INFECTIVITY OF TYPE 4 ECHOVIRUS-ANTIBODY COMPLEX.

Authors:  C WALLIS; J L MELNICK
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

2.  Typing of ECHO virus isolates by immune serum pools. The "intersecting serum scheme".

Authors:  N J SCHMIDT; R W GUENTHER; E H LENNETTE
Journal:  J Immunol       Date:  1961-11       Impact factor: 5.422

3.  Typing of viruses by combinations of antiserum pools. Application to typing of enteroviruses (Coxsackie and ECHO).

Authors:  K A LIM; M BENYESH-MELNICK
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

4.  Virus aggregation as the cause of the non-neutralizable persistent fraction.

Authors:  C Wallis; J L Melnick
Journal:  J Virol       Date:  1967-06       Impact factor: 5.103

5.  Preparation of antiserum to enteroviruses in large animals.

Authors:  B Hampil; J L Melnick; C Wallis; R W Brown; E T Braye; R R Adams
Journal:  J Immunol       Date:  1965-11       Impact factor: 5.422

6.  WHO collaborative studies on enterovirus reference antisera.

Authors:  J L Melnick; B Hampil
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

7.  WHO collaborative studies on enterovirus reference antisera; fourth report.

Authors:  J L Melnick; B Hampil
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

8.  WHO collaborative studies on enterovirus reference antisera. Third report.

Authors:  J L Melnick; B Hampil
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

9.  WHO collaborative studies on enterovirus reference antisera: second report.

Authors:  B Hampil; J L Melnick
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  9 in total
  15 in total

1.  Comparison of molecular and conventional methods for typing of enteroviral isolates.

Authors:  Darly Joseph Manayani; R V Shaji; G John Fletcher; Thomas Cherian; N Murali; N Sathish; Tilak Solomon; Chandran Gnanamuthu; Gopalan Sridharan
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008.

Authors:  Sheng-Wen Huang; Yun-Wei Hsu; Derek J Smith; David Kiang; Huey-Pin Tsai; Kuei-Hsiang Lin; Shih-Min Wang; Ching-Chung Liu; Ih-Jen Su; Jen-Ren Wang
Journal:  J Clin Microbiol       Date:  2009-09-23       Impact factor: 5.948

3.  Differentiation and characterization of enteroviruses by computer-assisted viral protein fingerprinting.

Authors:  D T Holland; J Senne; C R Peter; C Urmenta; J D Connor
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 4.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Rapid and sensitive detection of enteroviruses in specimens from patients with aseptic meningitis.

Authors:  S Yerly; A Gervaix; V Simonet; M Caflisch; L Perrin; W Wunderli
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture.

Authors:  A Trabelsi; F Grattard; M Nejmeddine; M Aouni; T Bourlet; B Pozzetto
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Molecular identification and typing of enteroviruses isolated from clinical specimens.

Authors:  Stefania Manzara; Michele Muscillo; Giuseppina La Rosa; Cinzia Marianelli; Paola Cattani; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

8.  Typing of human enterovirus by partial sequencing of VP2.

Authors:  Dorsaf Nasri; Lamjed Bouslama; Shabir Omar; Henia Saoudin; Thomas Bourlet; Mahjoub Aouni; Bruno Pozzetto; Sylvie Pillet
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

9.  Natural recombination event within the capsid genomic region leading to a chimeric strain of human enterovirus B.

Authors:  Lamjed Bouslama; Dorsaf Nasri; Lionel Chollet; Khaoula Belguith; Thomas Bourlet; Mahjoub Aouni; Bruno Pozzetto; Sylvie Pillet
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

10.  Prevalence, types, and RNA concentrations of human parechoviruses, including a sixth parechovirus type, in stool samples from patients with acute enteritis.

Authors:  Sigrid Baumgarte; Luciano Kleber de Souza Luna; Klaus Grywna; Marcus Panning; Jan Felix Drexler; Claudia Karsten; Hans Iko Huppertz; Christian Drosten
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.